1Jin RJ, Kwak C, Lee SG, et al. The application of an anti-angiogenic gene( thrombospondin-1 ) in the treatment of human prostate cancer xenografts. Cancer Gene Ther ,2000,7(12): 1537
2Zhang Y, Griffith EC,Sage J, et al. Cell cycle inhibition by the antiangiogenic agent TNP-470 is mediated by p53 and p21 WAF1/CIP1.Proc NatlAcad Sci USA,2000,97(12):6427
3Aparicio T, Kermorgant S, Dessirer V, et al. Matrix matalloproteinase inhibition prevents cokon caner peritoneal carcinomatcosis development and prolorgs survival in rats. Carcinogenesis, 1999,20(8): 1445
4Primorse JN,Bleiberg H,Daniel F, et al. Marimastat in recurrent colortal cancer exploratory evaluation of biological activity by measurement of carcinoembryonic antigen. Br J Cancer, 1999,79 (3-4): 509
5Dixon SC,Kruger EA,Bauer KS, et al. Thalidomide up regulates prostate specific antigen secretion from LNCaP cells. Cancer Chemother Pharmacol,1999,43:78
6Martinet O, Ermekova V, Qiao JQ, et al. Immunomodulatory gene therapy with interlukin-12 and 4-1BB ligand :long-term remission of liver metastses in a mouse model. J Natl Cancer Inst, 2000, 92(11):931
7Bruns CJ, Liu W, Davis DW, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endithelium in a murine model of colorectal carcinoma liver metastases. Cancer, 2000, 89(3):488
8Cao YO, Reilly MS, Marshall B, et al. Expression of angiostatin eDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases J Clim Imaest,1998,101:1055
9Sauter BV,Martinet O, Zhang WJ, et al. Adenovirus-mediated gene transfer endostatin in vivo results in high level of transgene expres sion and inhibition of tumor growth and metastases. Proc Natl A cad Sci USA ,2000,97(9) :4802
10Li H, Lu H, Griscelli F, et al. Adenovirus-mediated delivery of a uPA/uPAR antagnistns suppresses angiogenesis-depended tumor growth and dissemination in mice. Gene Ther, 1998,5: 1105
